CLINICAL TRIALS Cancer Clinical Trials During COVID-19

March 2020

Clinical Trials During COVID-19

COVID-19 is changing all aspects of medical care, including clinical trials. The FDA has established guidelines to help researchers during this critical time. Individual hospitals are developing their own policies for recruiting patients to clinical trials and keeping other trials on pace. Pharmaceutical and biotech companies are also having to make difficult decisions.

Below you will find information about new policies and guidelines. If you are on a clinical trial or considering a clinical trial, talk to your doctor or the clinical trial team to learn how your hospital and your trial may be affected. For all COVID-19 related information, visit the COVID-19 & Breast Cancer main page.

Impact of COVID-19 on Cancer Clinical Trials 

FDA Guidance on Clinical Trials

Changes of Clinical Trials by Sponsors and Research Sites 


Leave a Reply